Venus Concept (VERO) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
A special meeting of stockholders is scheduled for February 14, 2025, to consider a single proposal: authorizing the board to effect a reverse stock split at a ratio between 5:1 and 16:1, at the board's discretion, within one year of approval.
The reverse stock split aims to increase the share price to regain compliance with Nasdaq's minimum bid price requirement, following a deficiency notice and an extension to April 7, 2025, to cure the deficiency.
The board recommends voting in favor of the proposal, emphasizing the risk of delisting and reduced liquidity if the split is not approved.
Voting matters and shareholder proposals
Only one proposal is on the agenda: granting the board authority to implement a reverse stock split at a ratio of not less than 5:1 and not greater than 16:1, without reducing the authorized number of shares.
The board has discretion to select the final ratio and timing within one year of the meeting, or to abandon the split if deemed not in the best interest of stockholders.
Approval requires a majority of shares present or represented by proxy; abstentions and broker non-votes count as votes against.
Board of directors and corporate governance
The board, led by CEO Rajiv De Silva, is responsible for recommending and potentially implementing the reverse stock split.
No director or executive officer has a substantial interest in the proposal beyond their share ownership.
Latest events from Venus Concept
- Revenue down 17% year-over-year, but debt reduced and margin improved amid ongoing risks.VERO
Q2 20241 Feb 2026 - Q3 2024 revenue fell 15% year-over-year as debt was cut by 54% and losses persisted.VERO
Q3 202414 Jan 2026 - Revenue fell 13% in Q4 and 15% for FY24; debt cut by 47% and Q1 2025 revenue to exceed $14M.VERO
Q4 202424 Dec 2025 - Shelf registration enables up to $30.4M in securities sales for global medical technology expansion.VERO
Registration Filing16 Dec 2025 - Shareholders to vote on director elections, auditor ratification, and key share issuance proposals.VERO
Proxy Filing1 Dec 2025 - Shareholders to vote on director elections, auditor ratification, and major share issuances.VERO
Proxy Filing1 Dec 2025 - Vote sought on a reverse stock split to maintain Nasdaq listing and avoid delisting risk.VERO
Proxy Filing1 Dec 2025 - Approval sought for share issuance tied to convertible notes after major debt restructuring.VERO
Proxy Filing1 Dec 2025 - Amended registration statement for a public offering, with auditor consent and executive sign-off.VERO
Registration Filing29 Nov 2025